Category: VAERS

Antibody dependent enhancement: Unavoidable problems in vaccine development

Posted on | Posted on John Murphy | Leave a Comment on Antibody dependent enhancement: Unavoidable problems in vaccine development

Authors: Lele Xu, Zhiqian Ma, Yang Li, Zhaoxia Pang, and Shuqi Xiao* Adv Immunol. 2021; 151: 99–133.Published online 2021 Sep 4. doi: 10.1016/bs.ai.2021.08.003 PMCID: PMC8438590PMID: 34656289 Abstract In some cases, antibodies can enhance virus entry and replication in cells. This phenomenon is called antibody-dependent infection enhancement (ADE). ADE not only promotes the virus to be recognized by the target cell and enters the target […]

Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Posted on | Posted on John Murphy | Leave a Comment on Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Authors: Flor M. Munoz,a,⁎Jakob P. Cramer,bCornelia L. Dekker,cMatthew Z. Dudley,dBarney S. Graham,eMarc Gurwith,fBarbara Law,gStanley Perlman,hFernando P. Polack,iJonathan M. Spergel,jEva Van Braeckel,kBrian J. Ward,lArnaud M. Didierlaurent,mPaul Henri Lambert,m and for the Brighton Collaboration Vaccine-associated Enhanced Disease Working Group Abstract This is a Brighton Collaboration Case Definition of the term “Vaccine Associated Enhanced Disease” to be utilized in […]

COVID-19 vaccine surveillance report Week 3

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 vaccine surveillance report Week 3

Latest UK Data Shows Covid Infection RATE Among the Triple Jabbed (Boosted) Is HIGHER And RISING FASTER Than The Unvaccinated Across ALMOST EVERY Age Group 20 January 2022 Executive summaryFour coronavirus (COVID-19) vaccines have now been approved for use in the UK. Rigorousclinical trials have been undertaken to understand the immune response, safety profile andefficacy […]

VAERS Summary for COVID-19 Vaccines through 11/05/2021

Posted on | Posted on John Murphy | Leave a Comment on VAERS Summary for COVID-19 Vaccines through 11/05/2021

Official Reported Vaccine Adverse Events in the FDA Data Base For a Complete Report of All Vaccine Reported Adverse Events Through November 5th, 2021 Click Link Below: http://vaersanalysis.info/wp-content/uploads/2021/11/VAERS-Summary-11052021-3.pdf